Table 5 ADMET predictions by pkCSM
From: Characterization and In-silico toxicity prediction of degradation products of felbamate
Compound | Intestinal absorption (%absorbed) | PgP Substrate | BBB Permeability (log BB) | CYP1A2 inhibitor | CYP2C19 inhibitor | CYP2C9 Inhibitor | CYP2D6 Inhibitor | CYP3A4 Inhibitor | AMES toxicity | Hepatotoxicity |
|---|---|---|---|---|---|---|---|---|---|---|
Felbamate | 67.85 | No | − 0.206 | No | No | No | No | No | No | Yes |
DP1 | 96.10 | No | 0.516 | Yes | No | No | No | No | No | No |
DP2 | 95.16 | No | 0.125 | Yes | No | No | No | Yes | Yes | No |